All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.

The GvHD Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Introducing

Now you can personalise
your GvHD Hub experience!

Bookmark content to read later

Select your specific areas of interest

View content recommended for you

Find out more
  TRANSLATE

The GvHD Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the GvHD Hub cannot guarantee the accuracy of translated content. The GvHD Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact
Visit:
ALL Hub

ALL Hub

AML Hub

AML Hub

Lupus Hub

Lupus Hub

Lymphoma Hub

Lymphoma Hub

MPN Hub

MPN Hub

Multiple Myeloma

Multiple Myeloma Hub

PsOPsA Hub

PsOPsA Hub

LOADING
You're logged in! Click here any time to manage your account or log out.
LOADING
You're logged in! Click here any time to manage your account or log out.
Steering CommitteeAbout UsNewsletterContact

Brought to you by

Scientific Education Support logo

The GvHD Hub is an independent medical education platform, sponsored by Medac and supported through grants from Sanofi and Therakos. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.

TypesTherapeuticsCongressesTrialsExpert OpinionsEducational ResourcesDRUG UPDATES
2020-09-03T07:56:42.000Z

Do pre-transplant depression and anxiety impact on the development of GvHD?

By Georgia Scurfield, Alice Hyde
Featured
Zinaida Peric
Sep 3, 2020
Share:

Bookmark this article

During the 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the GvHD Hub spoke to Zinaida Peric, University Hospital Centre Zagreb, Zagreb, HR, about the results of a study performed by the Transplant Complications Working Party of the EBMT. We asked, Do pre-transplant depression and anxiety impact on the development of GvHD?

Do pre-transplant depression and anxiety impact on the development of GvHD?


Post-transplant depression is known to greatly impact the outcome of transplantation, and therefore, the effects of pre-transplant depression and anxiety are also of interest. Zinaida Peric reports on the results of the analysis of over 9,000 cases in the EBMT registry.


More about...
Acute graft-versus-host diseaseEBMT 2020

Your opinion matters

HCPs, what is your preferred format for educational content on the GvHD Hub?
8 votes - 25 days left ...

Related articles

Add bookmark

What should supportive care look like for patients with GvHD? What role does physical activity play in these patients?

During the 48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the GvHD Hub was pleased to...

Apr 14, 2022
Add bookmark

What should supportive care look like for patients with GvHD? What role does physical activity play in these patients?

During the 48th Annual Meeting of the European Society for Blood and Marrow...

Apr 14, 2022
Add bookmark

The impact of JAK inhibitor use on HSCT outcome in patients with MPN

Barabanshikova and colleagues analyzed outcomes of patients with MPN undergoing allo-HSCT with or without prior JAK inhibitor treatment and recently presented their work at the 46th...

Oct 8, 2020
Add bookmark

The impact of JAK inhibitor use on HSCT outcome in patients with MPN

Barabanshikova and colleagues analyzed outcomes of patients with MPN undergoing allo-HSCT with or without prior JAK inhibitor...

Oct 8, 2020

Newsletter

Subscribe to get the best content related to GvHD delivered to your inbox